Shanghai Rightongene (China) Investor Sentiment

688217 Stock   19.59  0.01  0.05%   
About 56% of Shanghai Rightongene's investor base is looking to short. The analysis of the overall investor sentiment regarding Shanghai Rightongene Biotechnology suggests that many traders are alarmed. The current market sentiment, together with Shanghai Rightongene's historical and current headlines, can help investors time the market. In addition, many technical investors use Shanghai Rightongene stock news signals to limit their universe of possible portfolio assets.
  
over two weeks ago at news.google.com         
Tranche Update on Shanghai Rightongene Biotechnology Co., Ltd.s Equity Buyback Plan announced on Feb...
Google News at Macroaxis
over three weeks ago at news.google.com         
Shanghai Rightongene Biotechnology Co., Ltd.s market cap dropped CN165m last week Individual investo...
Google News at Macroaxis
over two months ago at news.google.com         
How AstraZenecas China fraud was about more than greed - ThinkChina
Google News at Macroaxis
over two months ago at news.google.com         
Cover Story How AstraZenecas China Fraud Was About More Than Greed - Caixin Global
Google News at Macroaxis
over two months ago at news.google.com         
Chairman, Other Execs of Chinas Rightongene Are Held on Suspicion of Fraud - Yicai Global
Google News at Macroaxis
over three months ago at news.google.com         
Individual investors who hold 33 percent of Shanghai Rightongene Biotechnology Co., Ltd. gained 17, ...
Google News at Macroaxis
over six months ago at news.google.com         
Shanghai Rightongene Biotechnology Co., Ltd. Looks Inexpensive After Falling 28 percent But Perhaps ...
Google News at Macroaxis
over six months ago at news.google.com         
Japans stock market rally will continue in the second half, but with a key shift, BlackRock says - C...
Google News at Macroaxis
over six months ago at news.google.com         
Shanghai Rightongene Biotechnology First Quarter 2024 Earnings EPS CN0.01 - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Jinxi Axle First Quarter 2024 Earnings CN0.02 loss per share - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
China Reform Culture Holdings Full Year 2023 Earnings Misses Expectations - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Sangfor Technologies First Quarter 2024 Earnings Misses Expectations - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Investors Can Find Comfort In Shanghai Rightongene Biotechnologys Earnings Quality - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
EmbedWay Technologies Full Year 2023 Earnings Misses Expectations - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
ValueHD Corporations Popularity With Investors Under Threat As Stock Sinks 30 percent - Simply Wall ...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Shanghai Rightongene that are available to investors today. That information is available publicly through Shanghai media outlets and privately through word of mouth or via Shanghai internal channels. However, regardless of the origin, that massive amount of Shanghai data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Shanghai Rightongene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Shanghai Rightongene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Shanghai Rightongene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Shanghai Rightongene alpha.

Shanghai Rightongene Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Chairman, Other Execs of Chinas Rightongene Are Held on Suspicion of Fraud - Yicai Global
10/28/2024
2
Tranche Update on Shanghai Rightongene Biotechnology Co., Ltd.s Equity Buyback Plan announced on February 29, 2024. - Marketscreener.com
01/03/2025

Complementary Tools for Shanghai Stock analysis

When running Shanghai Rightongene's price analysis, check to measure Shanghai Rightongene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Rightongene is operating at the current time. Most of Shanghai Rightongene's value examination focuses on studying past and present price action to predict the probability of Shanghai Rightongene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Rightongene's price. Additionally, you may evaluate how the addition of Shanghai Rightongene to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device